1. Selective Lateral Pelvic Lymph Dissection for Rectal Cancer

   • George J. Chang

   Colorectal Cancer 27 September 2017 Pages: 3797 - 3798

2. “Total Mesenteric Peritonectomy for Peritoneal Metastases” (with Video) by Jean-Baptiste Cazauran et al.

   • Paul H. Sugarbaker

   Gastrointestinal Oncology 10 October 2017 Pages: 3799 - 3800

3. Discussion of “Microsurgical Reconstruction Following Oncologic Resection in Pediatric Patients: A 15-Year Experience” by M. Starnes-Roubaud et al.

   • Rebecca M. Garza
   • David W. Chang

   Reconstructive Oncology 01 September 2017 Pages: 3801 - 3802

4. Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-Analysis

   • Madalyn G. Neuwirth
   • Yun Song
   • Giorgos C. Karakousis

   Bone and Soft Tissue Sarcomas 11 October 2017 Pages: 3803 - 3810

   

5. Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion

   • Sam Pakraftar
   • Lekshmi Ramalingam
   • Haroon A. Choudry

   Colorectal Cancer 10 October 2017 Pages: 3811 - 3817

   

6. Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy

   • Danielle R. Heller
   • Cody Chiuzan
   • Michael D. Kluger

   Gastrointestinal Oncology 12 October 2017 Pages: 3818 - 3824

   

7. Frailty Correlates with Postoperative Mortality and Major Morbidity After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

   • Ioannis T. Konstantinidis
   • Konstantinos Chouliaras
   • Konstantinos I. Votanopoulos

   Gastrointestinal Oncology 10 October 2017 Pages: 3825 - 3830

   

8. Conflicting Data on the Incidence of Leukopenia and Neutropenia After Heated Intraperitoneal Chemotherapy with Mitomycin C

   • Yael Feferman
   • Shanel Bhagwandin
   • Umut Sarpel

   Gastrointestinal Oncology 12 October 2017 Pages: 3831 - 3836

   

9. Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C

   • Krystle N. Lange
   • Danielle McKay
   • Jan Franko

   Gastrointestinal Oncology 10 October 2017 Pages: 3837 - 3841

   

10. Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions

    • Cristina O’Donoghue
    • Matthew C. Perez
    • Jonathan S. Zager

    Melanomas 10 October 2017 Pages: 3842 - 3849

    

11. Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer

    • Yuichiro Miyake
    • Tsunekazu Mizushima
    • Hirofumi Yamamoto

    Colorectal Cancer 18 September 2017 Pages: 3850 - 3856

    

12. Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases

    • Claudius Conrad
    • Jean-Nicolas Vauthey
    • Y. Nancy You

    Colorectal Cancer 19 September 2017 Pages: 3857 - 3864

    

13. Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors

    • Sepideh Gholami
    • Michael R. Cassidy
    • Murray Brennan

    Bone and Soft Tissue Sarcomas 16 October 2017 Pages: 3865 - 3871

    

14. Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303

    • R. De Sanctis
    • L. Giordano
    • A. Gronchi

    Bone and Soft Tissue Sarcomas 17 October 2017 Pages: 3872 - 3879

    

15. Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival

    • Justin M. M. Cates

    Bone and Soft Tissue Sarcomas 20 October 2017 Pages: 3880 - 3887

    

16. Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy

    • Shirin Muhsen
    • Andrea V. Barrio
    • Kimberly J. Van Zee

    Breast Oncology 21 August 2017 Pages: 3888 - 3895

    

17. Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer

    • Lori F. Gentile
    • George Plitas
    • Andrea V. Barrio

    Breast Oncology 15 September 2017 Pages: 3896 - 3902

18. Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer

    • Robert C. Keskey
    • A. Scott LaJoie
    • Nicolas Ajkay

    Breast Oncology 16 October 2017 Pages: 3903 - 3910

    

19. Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy

    • Sheraz R. Markar
    • Caroline Gronnier
    • on Behalf of the FREGAT Working Group—FRENCH—AFC

    Gastrointestinal Oncology Open access 25 September 2017 Pages: 3911 - 3920

    

20. Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma

    • Katrin Schwameis
    • Kyle M. Green
    • Steven R. DeMeester

    Gastrointestinal Oncology 03 October 2017 Pages: 3921 - 3925

    

21. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis

    • Brett L. Ecker
    • Charles C. Vining
    • Jashodeep Datta

    Gastrointestinal Oncology 26 September 2017 Pages: 3926 - 3933

    

22. The Surgical Apgar Score Predicts Not Only Short-Term Complications But Also Long-Term Prognosis After Esophagectomy

    • Akio Nakagawa
    • Tetsu Nakamura
    • Yoshihiro Kakeji

    Gastrointestinal Oncology 06 October 2017 Pages: 3934 - 3946

    

23. Cross-Sectional Location of Gastric Cancer Affects the Long-Term Survival of Patients as Tumor Invasion Deepens

    • Yoon Ju Jung
    • Ho Seok Seo
    • Han Hong Lee

    Gastrointestinal Oncology 04 October 2017 Pages: 3947 - 3953

    

24. Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma

    • Suguru Yamashita
    • Michael J. Overman
    • Claudius Conrad

    Gastrointestinal Oncology 04 October 2017 Pages: 3954 - 3963

    

25. Comparison of Young Patients with Gastric Cancer in the United States and China

    • Vivian E. Strong
    • Ashley Russo
    • Chang-Ming Huang

    Gastrointestinal Oncology 19 October 2017 Pages: 3964 - 3971

    

26. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome

    • Michael J. Cavnar
    • Lin Wang
    • Philip B. Paty

    Gastrointestinal Oncology 20 October 2017 Pages: 3972 - 3980

    

27. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer

    • Glauco Baiocchi
    • Henrique Mantoan
    • Alexandre Andre Balieiro Anastacio da Costa

    Gynecologic Oncology 20 October 2017 Pages: 3981 - 3987

    

28. Total Mesenteric Peritonectomy for Peritoneal Metastases (with video)

    • Jean-Baptiste Cazauran
    • Antoinette Lasseur
    • Olivier Glehen

    Gastrointestinal Oncology 06 October 2017 Pages: 3988 - 3989

29. Ex Situ Hepatectomy and Liver Autotransplantation for Cholangiocarcinoma

    • Emilio Vicente
    • Yolanda Quijano
    • Riccardo Caruso

    Hepatobiliary Tumors 11 October 2017 Pages: 3990 - 3990

30. Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

    • Mark B. Faries
    • Nicola Mozzillo
    • MMAIT-IV Clinical Trial Group

    Melanomas 10 October 2017 Pages: 3991 - 4000

    

31. Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis

    • Anna Torgeson
    • Shane Lloyd
    • Randa Tao

    Radiation Oncology 17 October 2017 Pages: 4001 - 4008

    

32. Microsurgical Reconstruction Following Oncologic Resection in Pediatric Patients: A 15-Year Experience

    • Margaret J. Starnes-Roubaud
    • Matthew M. Hanasono
    • Edward I. Chang

    Reconstructive Oncology 07 September 2017 Pages: 4009 - 4016

    

33. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma

    • Pinjie Bao
    • Takehiko Yokobori
    • Hiroyuki Kuwano

    Thoracic Oncology 20 September 2017 Pages: 4017 - 4024

    

34. High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

    • Kotaro Yamashita
    • Hiroshi Miyata
    • Yuichiro Doki

    Translational Research and Biomarkers 11 October 2017 Pages: 4025 - 4032

    

35. Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status

    • Yuan-Ching Chang
    • Chi-Kuan Chen
    • Chien-Liang Liu

    Translational Research and Biomarkers 25 July 2017 Pages: 4033 - 4041

    

36. Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer

    • Julia Y. S. Tsang
    • Kit-Wing Chan
    • Gary M. Tse

    Translational Research and Biomarkers 13 June 2017 Pages: 4042 - 4050

    

37. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival

    • Callisia N. Clarke
    • Michael S. Lee
    • Scott Kopetz

    Translational Research and Biomarkers 21 September 2017 Pages: 4051 - 4058

    

38. Loss of Stromal Antigen 2 (STAG2) Expression in Upper Urinary Tract Carcinoma: Differential Prognostic Effect According to the Ki-67 Proliferating Index

    • Jimpei Miyakawa
    • Teppei Morikawa
    • Masashi Fukayama

    Urologic Oncology 02 October 2017 Pages: 4059 - 4066

    

39. Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy

    • Minyong Kang
    • Chun Tae Chang
    • Hyun Moo Lee

    Urologic Oncology 03 October 2017 Pages: 4067 - 4075